{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-079087","form_type":"8-K","ticker":"PVLA","cik":"0001583648","company_name":"PALVELLA THERAPEUTICS, INC.","filed_at":"2026-06-30T11:36:57+00:00","discovered_at":"2026-06-30T11:40:00.190468+00:00","generated_at":"2026-06-30T11:40:09.183770+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Palvella Therapeutics appoints Matthew Pauls to Board of Directors","bullets":["Board expanded from 7 to 8 members; Pauls appointed as Class I director effective June 29, 2026.","Pauls is CEO of Savara (NASDAQ: SVRA) and has led rare disease biopharma companies including Strongbridge.","He received an option to purchase 6,000 shares vesting monthly over 36 months under the Director Compensation Policy.","Board determined Pauls is independent under Nasdaq listing rules; no related party transactions disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-079087","json":"https://secwatch.observer/filing/0001104659-26-079087.json","markdown":"https://secwatch.observer/filing/0001104659-26-079087.md","text":"https://secwatch.observer/filing/0001104659-26-079087.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926079087/0001104659-26-079087-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926079087/tm2619348d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T11:40:09.183770+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b37263c4cd","claim":"Matthew Pauls was appointed as Class I director at PALVELLA THERAPEUTICS, INC..","evidence_excerpt":"appointed Matthew Pauls, to serve as a Class I director","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926079087/0001104659-26-079087-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class I director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}